Whitehawk Therapeutics, Inc. (3350)
XDUS
2.66
-0.30 (-10.14%)
Delayed Data
Oct 14, 2026, 06:00 AM
Day's Range
2.622.68
52 wk Range
1.654.54
Financial Statements - 3350 - Whitehawk Therapeutics, Inc.
Revenue
7.14M▼ 72.5%
Net Income
-20.59M▲ 67.7%Net Margin -288.3%
EBITDA
-107.78M▼ 77.6%
Free Cash Flow
-97.98M▼ 60.1%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 7.14M | 25.98M | 24.35M | 15.21M | 1M | 14M |
| Cost of Goods | 760K | 3.02M | 2.80M | 1.33M | 0 | - |
| Gross Profit | 6.38M | 22.95M | 21.54M | 13.88M | 1M | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -114.40M | -64.82M | -71.93M | -58.95M | -37.06M | -2.54M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 87.57M | -2.64M | -1K | -3.72M | -72.37M | -153K |
| Pre Tax Income | -20.59M | -63.69M | -65.76M | -60.51M | -110.08M | -3.47M |
| Income Tax | 0 | 0 | 0 | 0 | 2K | 2K |
| Net Income | -20.59M | -63.69M | -65.76M | -60.51M | -110.09M | -3.47M |
| EPS Basic | -0.33 | -2.36 | -2.44 | -2.69 | -12.41 | -0.214269 |
| EPS Diluted | -0.33 | -2.36 | -2.44 | -2.69 | -12.41 | -0.214269 |
| Basic Shares Outstanding | 61.88M | 27.02M | 29.14M | 23.42M | 9.28M | 21.68M |
| Diluted Shares Outstanding | 61.88M | 27.02M | 29.14M | 23.42M | 9.28M | 21.68M |
| Ebit | -20.59M | -63.53M | -65.53M | -60.28M | -109.42M | -2.66M |
| Ebitda | -107.78M | -60.70M | -65.36M | -56.40M | -35.35M | -2.65M |
| Net Income Continuous Operations | -20.59M | -63.69M | -65.76M | -60.51M | -110.09M | -3.47M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
